Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 375 | 370 | 0 | 0 | 0 |
| Gross Profit | 375 | 370 | N/A | N/A | N/A |
| Operating Expenses | 14,923 | 15,191 | 15,520 | 14,040 | 13,513 |
| Operating Income | -14,548 | -14,821 | -15,520 | -14,040 | -13,513 |
| Other Income | 501 | 358 | 218 | 215 | 145 |
| Pre-tax Income | -14,047 | -14,463 | -15,302 | -13,825 | -13,368 |
| Net Income Continuous | -14,047 | -14,463 | -15,302 | -13,825 | -13,368 |
| Net Income | $-14,047 | $-14,463 | $-15,302 | $-13,825 | $-13,368 |
| EPS Basic Total Ops | -4.30 | -4.80 | -5.90 | -5.30 | -5.20 |
| EPS Basic Continuous Ops | -4.27 | -4.77 | -5.85 | -5.26 | -5.23 |
| EPS Diluted Total Ops | -4.30 | -4.80 | -5.90 | -5.30 | -5.20 |
| EPS Diluted Continuous Ops | -4.27 | -4.77 | -5.85 | -5.26 | -5.23 |
| EBITDA(a) | $-14,172 | $-14,433 | $-15,130 | $-13,649 | $-13,132 |